Journal of Neurology Neurosurgery & Psychiatry · 1983 · 23 citations · 14 references
Life SciencesGeneticsImmunologyAutoimmunityHuman GeneticsImmunogeneticsAutoimmune Disease PathogenesisAutoimmune Disease Susceptibility GenesAutoimmune DiseasesGenetic Susceptibility To AutoimmunityHla TypingMyasthenia GravisHla Allele Frequency DistributionHla AllelesHla Autoimmune Disease AssociationsHla Genotype AssociationsHla ImmunogeneticsHla Risk AllelesMatched Control GroupThymic Hyperplasia
The HLA antigen distribution was studied in 37 north Indian patients with myasthenia gravis. The control group consisted of 118 normal, healthy individuals of the same ethnic group. The antigens showing the highest frequency were Bw21 (18.9% vs 4.2% p less than 0.005), Bw35 (24.3% vs 6.8%, p less than 0.005) and A9 (51.3% vs 30.5%, p less than 0.025). HLA-B8 was increased nearly two fold in the myasthenia gravis patients (RR = 2.4) and was confined mainly to the young females without thymoma. The possibility that Bw21 and Bw35 might be the markers for susceptibility to autoimmune disorders in India is discussed. The observations also support those of others that HLA-B8 linked susceptibility gene is more frequently found in myasthenia gravis patients with thymic hyperplasia.
14
Microdroplet Assay of Human Serum Cytotoxins
Paul I. Terasaki, John D. McClelland · Nature · 1964 · 2.1K citations
HL-A ANTIGENS IN MYASTHENIA GRAVIS
Dieter Fritze, C. Herrmann, Faramarz Naeim et al. · The Lancet · 1974 · 295 citations
Myasthenia Gravis, Autoantibodies, and HL-A Antigens
T. E. W. Feltkamp, P.M. van den Berg-Loonen, L. E. Nijenhuis et al. · BMJ · 1974 · 161 citations · Full text
Life Sciences, Immunology, Pathology +15
HL-A ANTIGENS IN MYASTHENIA GRAVIS
Dieter Fritze, Faramarz Naeim, Christian Herrman et al. · The Lancet · 1974 · 126 citations
Laurence M. Blendis, I. D. Ansell, Kenneth L. Jones · BMJ · 1970 · 83 citations · Full text